|
|
|
|
|
市場調査レポート
創薬市場におけるケモインフォマティクス
Strategic Analysis of World Cheminformatics in Drug Discovery Markets
|
当商品の販売は、2011年07月19日を持ちまして終了しました。
Abstract
Research Overview
Difficulty to Quantify Exact Benefits Cheminformatics Brings to Drug Discovery Reducing the Marketability
Though cheminformatics tools have been around for a long time, they clearly
quantify the productivity increments they bring around in the R&D process.
With many pharmaceutical companies tightening their budget for informatics
tools, there is a shift in the purchase decisions towards ROI calculations
rather than the price. It makes it easier for the decision makers in the
pharmaceutical companies to approve purchases of well validated tools, which
have a clear business case of good ROI.
Need for Data Integration and Knowledge Management Driving the Demand for the Informatics Tools
The globalisation of research efforts resulted in vast pools of scientific
resources spread across the globe for the pharmaceutical needs. There is an
increasing need for them to streamline the research efforts and effectively
utilise the information which is being created. Informatics tools such as
cheminformatics are playing a greater role to bring around integration and
knowledge management.
Developments in Computing Hardware Boosting the Uptake of More Complex Chemical Analytical and Modelling Tools
Computer hardware industry is witnessing a quantum jump in the capabilities of
computing power of the systems being sold. The systems are not only becoming
more powerful, but also cheaper bringing them within the reach of a vast
majority of scientists. With this new computing power, scientists are now able
to perform complex modeling and simulation exercises such as in-silico design
of drugs, virtual screening and docking experiments at speed which were never
witnessed before. High performance computing infrastructure in the
pharmaceutical companies is bringing around an increased uptake and
development of newer and sophisticated tools to effectively utilise this jump
in the computing power to solve the drug development challenges.
Table of Contents
- 1. Executive Summary
- 2. Exchange Rates and Glossary of Terms
- 1. Exchange Rates
- 1. Foreign Exchange Rates
- 2. Glossary of Terms
- 3. Cheminformatics Overview
- 1. Introduction
- 1. Introduction to Cheminformatics
- 2. Overview
- 3. Application Areas of Cheminformatics
- 4. Industry Challenges
- 1. Overview
- 2. Challenges and Issues
- 5. Market Engineering Research for World Cheminformatics Market
- 1. Market Overview
- 2. Market Segmentation
- 3. Market Engineering Measurements for World Cheminformatics Market
- 1. Market Engineering Measurements
- 4. Market Drivers for World Cheminformatics Market
- 5. Market Restraints for World Cheminformatics Market
- 6. World Cheminformatics Market - Revenue Forecasts
- 7. World Cheminformatics Markets - Geographical Trends
- 1. Geographic Contributions
- 8. World Cheminformatics Markets - Technology Trends
- 9. World Cheminformatics Market - Competitive Structure
- 6. Market Engineering Measurements for Data Management and Analysis Tools
Segment
- 1. Background
- 2. Market Overview
- 3. Revenue Forecasts
- 7. Market Engineering Measurements for Predictive Tools Segment
- 1. Introduction
- 2. Market Overview
- 3. Revenue Forecasts
- 8. Market Engineering Strategic Recommendations
- 1. Strategic Recommendations
- 1. Possible Recommendations
- 9. Database of Key Industry Participants
- 1. Database of Key Industry Participants
- 10. Decision Support Databases
- 1. Pharmaceutical R&D Expenditure
- 1. R&D Expenditure of Pharmaceutical Companies
- 2.Biotech Companies and Number of Employees
- 1. Number of Biotech Companies 2. Number of Employees in Biotech
Companies
- 3. Government R&D Expenditure
- 1. R&D Expenditure of Government
- 4. Private R&D Investment in Biotechnology
- 1. R&D Investment in Private Biotech Sector
|
 |
